FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes
WASHINGTON, D.C. — The U.S. Food and Drug Administration says that it recently approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an …
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes Read More